← FDA Drug Approvals (Drugs@FDA)
TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO · Approved 2023-06-13
Drug application
- FDA Application #
ANDA214008- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE
- Generic name
- Tipiracil Hydrochloride
- Active ingredients
- TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NATCO
- First approval
- 2023-06-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown